首页> 美国卫生研究院文献>other >In silico screening of the impact of hERG channel kineticabnormalities on channel block and susceptibility to acquired long QTsyndrome
【2h】

In silico screening of the impact of hERG channel kineticabnormalities on channel block and susceptibility to acquired long QTsyndrome

机译:在计算机上筛选hERG通道动力学的影响通道阻滞异常和对获得性长QT的敏感性综合症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Accurate diagnosis of predisposition to long QT syndrome is crucial for reducing the risk of cardiac arrhythmias. In recent years, drug-induced provocative tests have proved useful to unmask some latent mutations linked to cardiac arrhythmias. In this study we expanded this concept by developing a prototype for a computational provocative screening test to reveal genetic predisposition to acquired long-QT syndrome (aLQTS). We developed a computational approach to reveal the pharmacological properties of IKr blocking drugs that are most likely to cause aLQTS in the setting of subtle alterations in IKr channel gating that would be expected to result from benign genetic variants. We used the model to predict the most potentially lethal combinations of kinetic anomalies and drug properties. In doing so, we also implicitly predicted ideal inverse therapeutic properties of K channel openers that would be expected to remedy a specific defect. We systematically performed “in silico mutagenesis” by altering discrete kinetic transition rates of the Fink et al. Markov model of human IKr channels, corresponding to activation, inactivation, deactivation and recovery from inactivation ofIKr channels. We then screened and identified the properties ofIKr blockers that caused acquired long QT and therefore unmaskedmutant phenotypes for mild, moderate and severe variants. Mutant IKrchannels were incorporated into the O'Hara et al. human ventricularaction potential (AP) model and subjected to simulated application of a widevariety of IKr–drug interactions in order to identify thecharacteristics that selectively exacerbate the AP duration (APD) differencesbetween wild-type and IKr mutated cells. Our results show that drugswith disparate affinities to conformation states of the IKr channelare key to amplify variants underlying susceptibility to acquired long QTsyndrome, an effect that is especially pronounced at slow frequencies. Finally,we developed a mathematical formulation of the M54T MiRP1 latent mutation andsimulated a provocative test. In this setting, application of dofetilidedramatically amplified the predicted QT interval duration in the M54T hMiRP1mutation compared to wild-type.
机译:准确诊断长期QT综合征的易感性对于降低心律不齐的风险至关重要。近年来,已证明药物诱发性试验可用于揭示与心律不齐相关的某些潜在突变。在这项研究中,我们通过开发用于计算性筛选试验的原型来扩展此概念,以揭示遗传性易感性后天QT综合征(aLQTS)。我们开发了一种计算方法来揭示IKr阻断药物的药理学性质,这些药物最有可能在IKr通道门控的细微变化中引起aLQTS,这可能是由良性遗传变异引起的。我们使用该模型预测动力学异常和药物特性的最可能致命的组合。这样做,我们还隐含地预测了有望弥补特定缺陷的K通道开放剂的理想逆治疗性质。我们通过改变Fink等人的离散动力学转变速率来系统地进行“计算机诱变”。人类IKr通道的马尔可夫模型,对应于激活,失活,失活和失活恢复IKr通道。然后,我们筛选并确定了IKr阻滞剂导致获得较长的QT,因此未屏蔽轻度,中度和严重变异的突变表型。突变IKr通道被合并到O'Hara等人。人心室动作电位(AP)模型并经过广泛的模拟应用各种IKr-药物相互作用,以识别选择性加剧AP持续时间(APD)差异的特征在野生型和IKr突变细胞之间。我们的结果表明药物对IKr通道的构象状态有不同的亲和力放大变异对获得性长QT的潜在敏感性是关键综合症,这种现象在慢频率时尤为明显。最后,我们开发了M54T MiRP1潜在突变的数学公式,模拟了挑衅性的测试。在这种情况下,多芬利特的应用在M54T hMiRP1中显着放大了预测的QT间隔持续时间突变为野生型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号